Evolocumab – July 2026

  • Brand names:
    • Repatha®
  • Pharmaceutical Company:
    • AMGEN AUSTRALIA PTY LIMITED
  • Condition/Indication: Non-familial hypercholesterolaemia; Familial heterozygous hypercholesterolaemia; Familial homozygous hypercholesterolaemia
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026